
Join to view full profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 800-647-2098
Fax+1 314-362-3192
Dr. Baggstrom is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Maria Quintos Baggstrom MD FACP FASCO is an oncology specialist with a focus on thoracic cancer, based in St. Louis, MO. She completed her medical education at McGovern Medical School at UT Health and training at the University of North Carolina Hospitals. She is currently a Professor of Medicine at Washington University in St. Louis School of Medicine, where she has been part of the faculty since 2005. Her expertise includes lung, medical, and thoracic oncology. Dr. Baggstrom has contributed to research with a focus on clinical trials in lung cancer therapy and in racialized economic segregation in lung cancer care, among other topics. She has been recognized by the American Society of Clinical Oncology as an ASCO Education Scholar and with the FASCO award.
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 1999 - 2002
University of North Carolina HospitalsResidency, Internal Medicine, 1996 - 1999
McGovern Medical School at UTHealthClass of 1996
Certifications & Licensure
MO State Medical License 2004 - 2027
NC State Medical License 1997 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- FASCO American Society of Clinical Oncology, 2023
- ASCO Education Scholar American Society of Clinical Oncology, 2018
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2013-2014, 2016-2017
Clinical Trials
- A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
- Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2007 Mar 15
- Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Publications & Presentations
PubMed
- Health Insurance Type and Lung Cancer Stage Shift Following Coverage of Screening.Min Lian, Timothy McBride, Benjamin Kozower, Maria Baggstrom, Ying Liu
Health Services Research. 2026-08-01 - AOA Critical Issues Symposium: Allyship in Action.Shian L Peterson, Aaron M Brandt, Bethany J Adams, Maria Quintos Baggstrom, Dane H Salazar
The Journal of Bone and Joint Surgery. American Volume. 2025-09-17 - 1 citationsRacialized economic segregation and disparities in non-small cell lung cancer care and outcomes.Pratibha Shrestha, Min Lian, James Struthers, Oumarou Nabi, Bayu B Bekele
CHEST Pulmonary. 2025-03-01
Committees
- Member, ASCO Educational Council 2025 - Present
- Track Leader, ASCO Annual Meeting Scientific Program Committee 2023 - Present
- Member, AAMC GWIMS Steering Committee 2023 - Present
- Member, Chair, ASCO Membership Advisory Committee 2018 - 2023
Professional Memberships
- Fellow
- Member
- International Association for the Study of Lung CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









